Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

Tapering thrombopoietin receptor agonists in primary immune thrombocytopenia: Expert consensus based on the RAND/UCLA modified Delphi panel method

Abstract Background Thrombopoietin receptor agonists (TPO‐RAs) are used to treat primary immune thrombocytopenia (ITP). Some patients have discontinued treatment while maintaining a hemostatic platelet count. Objectives To develop expert consensus on when it is appropriate to consider tapering TPO‐R...

Full description

Bibliographic Details
Main Authors: Adam Cuker, Jenny M. Despotovic, Rachael F. Grace, Caroline Kruse, Michele P. Lambert, Howard A. Liebman, Roger M. Lyons, Keith R. McCrae, Vinod Pullarkat, Jeffrey S. Wasser, David Beenhouwer, Sarah N. Gibbs, Irina Yermilov, Michael S. Broder
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Research and Practice in Thrombosis and Haemostasis
Subjects:
blood platelets
consensus
idiopathic
platelet count
purpura
receptors
Online Access:https://doi.org/10.1002/rth2.12457

Internet

https://doi.org/10.1002/rth2.12457

Similar Items